Showing results (341-350 of 431) with videos related to
Sort By:
Pageof 44
Breast Cancer Research : BCR|June 13, 2024
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019Jenna Bhimani, Kelli O'Connell, Isaac J Ergas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.Cancer Treatment Reviews|February 1, 2008
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxelMinetta C Liu, George D Demetri, Donald A Berry, et al.NPJ Breast Cancer|March 11, 2022
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer modelsAnna R Michmerhuizen, Lynn M Lerner, Andrea M Pesch, et al.Cancer Cytopathology|March 25, 2011
Biospecimen reporting for improved study quality (BRISQ)Helen M Moore, Andrea B Kelly, Scott D Jewell, et al.Breast Cancer Research and Treatment|July 6, 2025
Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I-IIIA breast cancerJenna Bhimani, Peng Wang, Grace B Gallagher, et al.JCO Clinical Cancer Informatics|April 18, 2024
Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast CancerJenna Bhimani, Kelli O'Connell, Isaac J Ergas, et al.International Journal of Cancer|June 2, 2025
Patient factors and modifications to intended chemotherapy for women with Stages I-IIIA breast cancerJenna Bhimani, Peng Wang, Grace B Gallagher, et al.Cancer|March 11, 2026
The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancerJenna Bhimani, Kelli O'Connell, Victoria S Blinder, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2011
p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905)Jonathan F Lara, Ann D Thor, Lynn G Dressler, et al.Pageof 44